Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that are missing one gene copy, called loss of heterozygosity (LOH), was developed by researchers at the Ludwig Center, Lustgarten Laboratory and the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center.
New Brunswick, N.J. (June 1, 2020) – Rutgers University–New Brunswick Professor Ahmed Elgammal is available for interviews on the future of art and creativity in the age of artificial intelligence (A.I.). “As artificial intelligence becomes an increasing part of our…
New UNLV study finds that drivers of flashy cars are less likely to yield for pedestrians.
Yvonne Chen engineers immune cells to target their most evasive enemy: cancer. New cancer immunotherapies generate immune cells that are effective killers of blood cancers, but they have a hard time with solid tumors.
New Brunswick, N.J. (Oct. 1, 2019) – Street Smart NJ campaigns on pedestrian safety at intersections in eight communities reduced traffic violations and increased safety, according to a two-part study by the Rutgers Center for Advanced Infrastructure and Transportation (CAIT)…
The University of Illinois at Chicago’s 2019 Urban Forum, titled “Are we there yet? The myths and realities of autonomous vehicles,” will examine the questions and uncertainties surrounding not only the societal and legislative impact of autonomous vehicles, but also the technological advances needed for these vehicles to proliferate.
Scientists have discovered how diatoms – a type of algae that produces 20 percent of the Earth’s oxygen – absorb solar energy for photosynthesis. The Rutgers University-led discovery, published in the journal Proceedings of the National Academy of Sciences, could help lead to more efficient and affordable algae-based biofuels and combat climate change from fossil fuel burning.